Serveur d'exploration Tocilizumab - Checkpoint (PascalFrancis)

Index « Mots-clés originaux en anglais » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Keywords

Pour accéder à une entrée :

Les termes de plus forte occurence

179Tocilizumab
178Chronic
166Immunomodulator
147Rheumatology
146Rheumatoid arthritis
119Treatment
104Human
94Immunosuppressive agent
89Interleukin 6
47Antirheumatic agent
34Toxicity
30Biotherapy
28Antineoplastic agent
22Review
19Methotrexate
18Juvenile rheumatoid arthritis
17Monoclonal antibody
17Anti-Tumor Necrosis Factor-alpha
16Medicine
16Biological receptor
14Tumor necrosis factor
14Anti-TNF
13Bibliographic review
13Antibody
12Tumor necrosis factor α
12Inflammation
12Drug
12Comparative study
12Castleman disease
12Benign lymphadenopathy
12Abatacept
11Rituximab
11Prognosis
11Interleukin 6 receptor
11Cytokine
11Antipsoriatic agent
10Refractory
10Hematology
10Adalimumab
9Treatment efficiency
9Secondary effect
9Risk factor
9Joint
9Clinical trial
9Child
9Case study
9B-Lymphocyte
8Vasculitis
8Radiography
8Malignant tumor
8Inhibitor
8Infection
8Biological agent
7Systemic disease
7Remission
7Pharmacokinetics
7Inflammatory joint disease
7Autoimmune disease
7Adult
6Targeting
6Takayashu arteritis
6Still disease
6Spondylarthritis
6Efficiency
6Disseminated
6Complication
6Biological treatment
6Ankylosing spondylitis
5β Cell
5T-Lymphocyte
5Signal transduction
5Recommendation
5Psoriasis
5Pharmacodynamics
5Patient
5Intravenous administration
5Interleukin
5Infliximab
5In vivo
5Improvement
5Giant cell arteritis
5Etanercept
5Chemotherapy
5Biological activity
5Autoimmunity
5Antagonist
4Subcutaneous administration
4Relapsing polychondritis
4Randomization
4Pharmacovigilance
4Pharmacotherapy
4Nuclear magnetic resonance imaging
4Japan
4Drug interaction
4Drug combination
4Dermatology
4Certolizumab pegol
4Antiinflammatory agent
4Adolescent
3Tuberculosis
3Treatment resistance
3Targeted therapy
3Target
3Systemic lupus erythematosus
3Synovial membrane
3Soluble form
3Skin
3Single dose
3Serum
3Receptor activator Nfkb ligand
3Psoriatic arthritis
3Plasmocyte
3Pharmacokinetic pharmacodynamic relationship
3Parasiticide
3Nuclear medicine
3Monograph
3Monocyte
3Metaanalysis
3Mechanism of action
3Lesion
3Inflammatory disease
3Indication
3Immunoglobulins
3Immune response
3Hospital
3Herpes zoster
3French
3Failure
3Evolution
3Evaluation scale
3Doppler ultrasound study
3Corticosteroid
3Commercial form
3Canakinumab
3Bone
3Arthritis
3Antimalarial
3Antigen
3Animal
3Anatomic pathology
3Anakinra
3Activity index
2Woman
2Ulcer
2Tumor necrosis factor β
2Tolerance
2Technical card
2Synovitis
2Symptomatology
2Stromal cell
2Strategy
2Stiffness
2Stem cell
2Sjögren syndrome
2Scleroderma
2Safety
2Risk
2Recruitment
2Quantitative analysis
2Public health
2Protein
2Production
2Prevention
2Polymyalgia rheumatica
2Pharmacology
2Osteoclast
2Orthopedics
2Oral squamous cell carcinoma
2Oral cancer
2Oral administration
2Myeloma
2Multiple
2Multicenter study
2Mouse
2Monkey
2Medical screening
2Long term
2Interleukin-6 receptor
2Interferon
2Interest
2Injectable form
2Inhibition
2Inflammatory arthritis
2In vitro
2Immunotherapy
2Immunoprophylaxis
2Immunology
2Immunogenicity
2Hydroxychloroquine
2Hospital pharmacy
2Hand
2Golimumab
2Glycosylation
2Genetics
2Genetic variability
2Gene therapy
2Finger
2Fibroblast
2Female
2Evaluation
2Elderly
2Double blind study
2Dendritic cell
2Crohn disease
2Combined treatment
2Clinical management
2Cell
2Cell proliferation
2Cardiovascular disease
2Cancerology
2Bone marrow
2Blood
2Blood vessel
2Biopharmaceuticals
2Biological marker
2Arteritis
2Adenoviridae
2Acute
1α4β1 integrin
1pH
1Zone electrophoresis
1X ray
1Wrist
1West
1Volumetric analysis
1Viral hepatitis C
1Viral hepatitis B
1Vascular endothelium growth factor
1Vascular endothelial growth factor C
1Variant
1Validation
1Vaccination
1Uveitis
1Urinary incontinence
1Uric acid
1Updating
1United States
1United Kingdom
1Ultraviolet detector
1Ultrasound
1Ulceration
1Tumor necrosis factor receptor-associated periodic syndrome
1Transducer
1Transcription
1Transcription factor NFκB
1Tooth
1Toll like receptor
1Therapy
1Th17 lymphocyte
1Technology
1Technical progress
1Targeted prevention
1Systemic
1Systematic review
1Synthesis
1Syndrome
1Survival
1Surveillance
1Surgical approach
1Surgery
1Suppressor of cytokine signalling
1Suppressor of cytokine signaling 3
1Sulfasalazine
1Subcutaneous
1Streptococcal infection
1Spinal cord
1Sonography
1Small intestine
1Sleep disorder
1Skin cancer
1Simvastatin
1Signalling
1Short term
1Secretion
1Rodentia
1Rheumatoid nodule
1Result
1Restricted prescription
1Response
1Research and development
1Relapse
1Regulatory cell
1Regulation(control)
1Register
1Recycling
1Receptor activator Nfkb
1Reactive arthritis
1Reactivation
1Reaction
1Randomized controlled trial
1Radiology
1Quality of life
1Pustular psoriasis
1Purine
1Pulmonary hypertension
1Pulmonary fibrosis
1Pulmonary abscess
1Protein synthesis
1Procalcitonin
1Primitive
1Premature rupture of membrane
1Pregnancy
1Prednisone
1Prednisolone
1Predictive factor
1Preclinical trial
1Powder
1Posology
1Polymyositis
1Pneumopathy
1Placebo
1Phase composition
1Phase IV trial
1Phase III trial
1Phase I trial
1Pharmacogenetics
1Perfusion
1Performance evaluation
1Pediatrics
1Parenteral administration
1Pancreatitis
1Palmoplantaris pustulosis
1Pain
1P2X7 purinergic receptor
1Osteoporosis
1Osteopenia
1Osteoblast
1Oral cavity
1Optic nerve
1Opportunistic infection
1Ocrelizumab
1Obstetrics
1Observation
1Nutrition
1Norwegian scabies
1Non steroidal antiinflammatory agent
1New product
1Neutrophil
1Neutralization
1Neurooptic myelitis
1Nervous system diseases
1Neovascularization
1Necrotizing fasciitis
1Myositis
1Myopathy
1Myeloid cell
1Mutation
1Mucosa
1Monotherapy
1Mobile phase
1Mitogen-activated protein kinase
1Microcrystal
1Metabolism
1Mesothelioma
1Mesenchymal cell
1Meningitis
1Mechanism
1Malignant melanoma
1Malignancy
1M2 macrophage
1Lymphoma
1Lymphoid neoplasm
1Lymphangiogenesis
1Lung
1Lung nodule
1Lung disease
1Ligand
1Leukemia
1Leflunomide
1Latent tuberculosis
1Laboratory
1Laboratory investigations
1Kinase
1Kidney cancer
1Italian
1Isoimmunization
1Intracranial tumor
1Intestinal perforation
1Interstitial pneumonitis
1Interleukin 2
1Interleukin 20
1Interleukin 1
1Interleukin 17
1Interleukin 1 receptor antagonist
1Influenza
1Induction
1Inaugural sign
1Immunomodulation
1Immunological investigation
1IgG
1IgG4
1Identification
1Iatrogenic
1Hypouricemic agent
1Hypocholesterolemic agent
1Hyperviscosity syndrome
1Hyperbilirubinemia
1Humanized antibody
1Human immunodeficiency virus
1Hospitalization
1Homograft
1Homeostasis
1Hodgkin disease
1Hip joint
1Hepcidin
1Hepatitis
1Hemorrhage
1Hemophagocytic syndrome
1Hematopoietic cell
1Helper cell
1Heart failure
1Healthy subject
1Health insurance
1Health economy
1Health Assessment Questionnaire Stanford
1Harmlessness
1Hair
1Gynecology
1Growth
1Growth factor
1Grawitz tumor
1Granulocyte
1Gout
1Glucocorticoid
1Glioma
1Giant cell
1Geriatrics
1Genotype
1Genetic variant
1Genetic transfer
1Gene expression
1Gelatinase A
1Gabapentin
1France
1Foot sole
1Food and Drug Administration
1Fibrosis
1Fibronectin
1Fiber
1Fever
1Ferritin
1Fatigue
1Family study
1Familial mediterranean fever
1Factor XIII
1Factor XIII deficiency
1Extension
1Experience
1Europe
1Established cell line
1Epidemiology
1Enzyme immunoassay
1Endothelial dysfunction
1Emphysema
1Effector
1Echography
1Early
1ELISA assay
1Dilatation
1Differentiation
1Diet
1Diagnosis
1Dermoid cyst
1Dermatitis
1Denosumab
1Danish
1DNA
1Cytochrome P450
1Cryoglobulinemia
1Critical study
1Costs
1Cost efficiency analysis
1Coronary heart disease
1Contraindication
1Contraceptive
1Colon
1Collagen induced arthritis
1Colchicine
1Coagulopathy
1Coagulation factor
1Coagulation factor deficiency
1Clinical pharmacology
1Clearance
1Classification
1Chromosome
1Chloroquine
1Chimeric receptor
1Chemokine
1Chemical analysis
1Center
1Cell surface
1Cell microenvironment
1Cell maturation
1Cell differentiation
1Cell component
1Cell adhesion molecule
1Case control study
1Cartilage
1Cardiomyopathy
1Carcinoma

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/Tocilizumab.storage/TocilizumabV1/Data/PascalFrancis/Checkpoint/KwdEn.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021